Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 8-K Event Results of operations
  4. 10-Q Report Quarterly Report
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 8-K Event Results of operations · Other events
  8. 8-K Event Executive or director change
  9. 8-K Event Shareholder vote results
  10. 4 Insider Changes in Ownership
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 8-K Event Other events
  13. 8-K Event Results of operations
  14. 10-Q Report Quarterly Report
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. ARS Other Annual Report to Security Holders
  17. DEFA14A Proxy Proxy Materials
  18. DEF 14A Proxy Proxy Statement
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. S-3ASR Offering Registration Statement

Page 1 of 64 · 1,274 filings